DOMS Industries Ltd (DOMS) Q2 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

DOMS Industries, a leading Indian stationery and art materials maker with a baby hygiene arm in Uniclan, reports Q2 FY 2026-2027 with the spotlight squarely on whether margins have found a floor. The print will speak to the EBITDA margin trajectory against the guided 16%-17% range after Q1's 12.3%, and to the first full quarter of Reynolds consolidation alongside greenfield commissioning at Umbergaon.

DOMS Industries Ltd Q2 Results Date and Time

The board of DOMS Industries will meet on November 2, 2026, to approve the unaudited standalone and consolidated financial results for the quarter and six months ended September 30, 2026. The trading window for designated persons has been closed from October 1, 2026, until 48 hours after the results are announced.

A conference call to discuss the Q2 and H1 FY27 results is scheduled for November 3, 2026, at 5:00 pm IST, with CFO Rahul Shah representing the company. The call is organized by ICICI Securities.

What to expect from DOMS Industries Ltd's Q2 FY27 results

The central question for Q2 FY27 is whether EBITDA margin inflected from the 12.3% level management called a 'potential bottom', after raw material inflation of roughly 20% in Q1 against pricing actions of only 4%-5% left about 500 bps of cost pass-through still pending. The stabilization condition behind the guided ~16%-17% margin recovery did not materialize in the quarter — Brent crude rose about 14% in September after crossing $100 on September 9 and sat near $113-$116 into late October, keeping crude-linked input costs (about 40% of the raw material basket directly, another 30% indirectly) elevated, while analyst-flagged higher-cost inventory flow-through adds pressure to Q2 gross margins. On revenue, the setup is more supportive: Q1 grew 19.2% against the FY27 consolidated guidance of 18%-20%, management guided a scholastic segment growth pickup from Q2 FY27, the GST 2.0 base effect from the September 2025 rate cuts flatters the YoY comparison, and Reynolds (effective July 1, 2026) adds an inorganic layer in its first full quarter. Offsets sit in exports, which were about 12% of revenue in Q1 against a 13%-15% FY27 target, amid EU demand softness, US tariff noise and freight costs that saw India-bound tanker rates more than double to $250,000/day by mid-September. The call will also be watched for confirmation that the first greenfield building of 300,000 sq ft at Umbergaon started commercial production by end-Q2 FY27, and for the Uniclan SAP cost impact management guided to land in this quarter.

Key Things To Watch

Margin recovery path and Q2 EBITDA margin vs the 12.3% 'potential bottom': The quarter's swing factor is whether margins inflected or compressed for a second consecutive quarter.

• EBITDA margin guided to return to ~16%-17% 'once raw material prices stabilize' (open-ended timing); Q1 FY27 came in at 12.3% and management called it a 'potential bottom' — test whether Q2 inflected
• About 500 bps of raw material cost pass-through still pending, with a 4%-5% price increase taken against a ~20% average RM increase in Q1; management said it is not planning further hikes this quarter
• Analyst-flagged risk that higher-cost inventory consumed in Q2 could deplete gross margins further; watch the no-further-hikes stance against RM volatility

Reynolds first full quarter and greenfield commissioning: Q2 FY27 is the first quarter with accounting impact of the Reynolds APA, and the quarter in which the first greenfield building was targeted for commercial production.

• Reynolds APA of Rs. 3,500 lakhs (USD 3.7 Mn, excluding inventories) effective July 1, 2026 — watch initial revenue contribution, interim cost-apportionment impact on margins, and progress toward the guided ~16% Reynolds EBITDA margin and close to 10% of overall revenues by FY29
• First greenfield building (300,000 sq ft) targeted for commercial production by end of Q2 FY27 — confirm status and initial ramp-up; nine production buildings of ~150,000 sq ft each planned over the next 8-9 quarters
• Higher depreciation from capacity expansion and commissioning of new facilities pressured Q1 PAT — watch the step-up as more buildings commission

Revenue guidance tracking, Uniclan and exports: Growth, hygiene-segment costs and the export line carry specific guided targets to track.

• Consolidated revenue growth of 18%-20% for FY27 (reiterated on the Q1 call; 'high-teen' per the MD at the September 3, 2026 AGM) — Q1 FY27 grew 19.2%, in line with the guided range; watch whether Q2 sustains the run-rate
• Uniclan SAP cost impact guided to hit in Q2 after Q1 mitigation via advance purchase orders — watch Q2 Uniclan margin vs the 8%-9% annual expectation, partially offset by seasonal fixed-cost absorption from Q2
• Exports: FY27 target of 13%-15% of sales vs ~12% in Q1, with Q1 export growth flattish on EU softness and West Asia logistics disruption; watch recovery from freight normalization and US tariff developments